150 related articles for article (PubMed ID: 673918)
1. [Clinical pharmacology of cardiac glycosides].
Haustein KO
Pol Tyg Lek; 1978 May; 33(20):817-20. PubMed ID: 673918
[No Abstract] [Full Text] [Related]
2. [Preventive use of glycosides].
Jahrmärker H
Internist (Berl); 1973 Jul; 14(7):306-12. PubMed ID: 4270161
[No Abstract] [Full Text] [Related]
3. [Indications, contra-indications and dosage of cardiac glycosides controlled by plasma levels in the aged].
Hötter GJ
Z Gerontol; 1987; 20(1):8-12. PubMed ID: 3577317
[TBL] [Abstract][Full Text] [Related]
4. [Cardiac glycoside therapy].
Born H
Folia Clin Int (Barc); 1969 Nov; 17(11):534-45. PubMed ID: 5803723
[No Abstract] [Full Text] [Related]
5. [Cardiac glycoside therapy].
Michel D
Fortschr Med; 1971 Aug; 89(24):917-21. PubMed ID: 4262966
[No Abstract] [Full Text] [Related]
6. Current drug therapy: cardiac glycosides.
Am J Hosp Pharm; 1978 Dec; 35(12):1495-507. PubMed ID: 362913
[TBL] [Abstract][Full Text] [Related]
7. [Rational prescription of cardiac stimulants].
Rietbrock N; Abshagen U; von Bergmann K; Kewitz H
Dtsch Med J; 1972 Feb; 23(2):100-5. PubMed ID: 5017962
[No Abstract] [Full Text] [Related]
8. [Introduction to clinical pharmacodynamics and pharmacokinetics of cardiac glycosides].
Kudrin AN; Namakanov BA; Davydova ON
Sov Med; 1981; (11):70-4. PubMed ID: 7038899
[No Abstract] [Full Text] [Related]
9. [Cardioactive glycosides].
Egidi E
Minerva Nipiol; 1967; 17(4):121-31. PubMed ID: 5620853
[No Abstract] [Full Text] [Related]
10. [Treatment with digitalis].
Burkart F
Schweiz Rundsch Med Prax; 1977 Mar; 66(9):257-9. PubMed ID: 840830
[No Abstract] [Full Text] [Related]
11. [Quantitative studies on the therapeutic range of cardiac glycosides].
Diederen W; Kadatz R
Arztl Forsch; 1970 May; 24(5):149-55. PubMed ID: 5538016
[No Abstract] [Full Text] [Related]
12. [Digitalis and cardiac arrhythmias: experimental bases].
Méndez R
Arch Inst Cardiol Mex; 1979; 49(4):543-60. PubMed ID: 485665
[No Abstract] [Full Text] [Related]
13. Contribution of clinical pharmacology to a rational use of cardiac glycosides in Czechoslovakia.
Sechser T; Petrásek R; Stika L; Modr Z; Elis J; Malý J
Pol J Pharmacol Pharm; 1989; 41(6):527-32. PubMed ID: 2485902
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of heart failure, with special consideration of iatrogenic complications].
Lüderitz B; Avenhaus H
Munch Med Wochenschr; 1970 Oct; 112(40):1779-84. PubMed ID: 5536213
[No Abstract] [Full Text] [Related]
15. [Modifying factors in carciac glycoside therapy].
Krebs R
Med Klin; 1976 Oct; 71(42):1759-70. PubMed ID: 790134
[No Abstract] [Full Text] [Related]
16. [Current status of the treatment with cardiac glycosides].
Pomerantsev VP; Kopsalova SM
Sov Med; 1985; (7):44-8. PubMed ID: 4071234
[No Abstract] [Full Text] [Related]
17. [Therapy with cardiac glycosides].
Simon H
Hippokrates; 1976 Feb; 47(1):30-52. PubMed ID: 783095
[No Abstract] [Full Text] [Related]
18. [Principles of pharmacotherapy with cardiac glycosides].
Kukes VG; Volkov RIu
Revmatologiia (Mosk); 1983; (2):65-9. PubMed ID: 6353520
[No Abstract] [Full Text] [Related]
19. [Pharmacodynamics, pharmacokinetics and side effects of cardiac glycosides].
Sivkov II; Kukes VG; Ibadova DN; Shokhor VIa; Otdelenov AV
Vestn Akad Med Nauk SSSR; 1987; (9):83-7. PubMed ID: 3673236
[No Abstract] [Full Text] [Related]
20. [Present-day cardiac glycoside therapy].
Larbig D
Pol Arch Med Wewn; 1976 Dec; 56(6):551-65. PubMed ID: 794849
[No Abstract] [Full Text] [Related]
[Next] [New Search]
